Differential Protective Effects of Exenatide, an Agonist of GLP-1 Receptor and Piragliatin, a Glucokinase Activator in Beta Cell Response to Streptozotocin-Induced and Endoplasmic Reticulum Stresses
Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System | SpringerLink
Frontiers | GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects | Endocrinology
Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium - Journal of the Neurological Sciences
Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | SpringerLink
Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies - Metabolism - Clinical and Experimental
Spinal microglial β‐endorphin signaling mediates IL‐10 and exenatide‐induced inhibition of synaptic plasticity in neuropathic pain - Ma - 2021 - CNS Neuroscience & Therapeutics - Wiley Online Library
Exenatide, a GLP-1 receptor agonist, activates glucose transport in L6 muscle cell by an AMPK-dependent mechanism - Virtual Meeting | EASD
Mechanisms by which GLP-1 agonists may exert beneficial effects on the... | Download Scientific Diagram
Pharmacokinetic/pharmacodynamic studies on exenatide in diabetic rats | Acta Pharmacologica Sinica
A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology
Incretin - Wikipedia
GLP-1 receptor agonists in type 2 diabetes: An underused asset? Updated January 2021 - DiabetesontheNet
![dpp-4_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/dpp4.png?w=600&tok=f9724b "dpp-4_inhibitors [TUSOM | Pharmwiki]")
dpp-4_inhibitors [TUSOM | Pharmwiki]
Frontiers | GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms | Pharmacology
Frontiers | GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects | Endocrinology
![exenatide [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c "exenatide [TUSOM | Pharmwiki]")
exenatide [TUSOM | Pharmwiki]
Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes - Clinical Therapeutics
Recent updates on GLP-1 agonists: Current advancements & challenges - ScienceDirect
Exendin‐4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant - Yap - 2019 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
Exenatide - Wikipedia
Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors | Circulation
Structures of native GLP-1, exenatide, and liraglutide. The N-terminal... | Download Scientific Diagram
A schematic representation of the mechanisms of increased macrophage... | Download Scientific Diagram
Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus
